Doctor profile · Federal record
Dr. Olusola Ogundipe, M.D.
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Valparaiso, IN
- NPI 1194849901
- Accepts Medicare
- 43 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
2600 Roosevelt RD
Valparaiso, IN 463830970
(219) 464-1620
fax (219) 477-4565 - Mailing address
-
342 E 109Th Ave
Crown Point, IN 463078693
Credentials & registration
- NPI registered
- March 2007 — 19 yrs on file
- Profile last updated
- April 16, 2021
- Year of graduation
- 1983 — 43 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Indiana #10165962A
- Medicaid
- IN #200922610
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1194849901. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
31,568
Distinct HCPCS
10
Medicare allowed
$446,404
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,240 | 21 | $23 | |
J1437 |
Injection, ferric derisomaltose, 10 mg | 1,600 | 12 | $21 | |
36415 |
Insertion of needle into vein for collection of blood sample | 1,452 | 240 | $8 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,436 | 240 | $8 | |
84132 |
Blood potassium level | 1,337 | 235 | $5 | |
82435 |
Blood chloride level | 1,336 | 235 | $5 | |
84295 |
Blood sodium level | 1,336 | 235 | $5 | |
82247 |
Bilirubin level, total | 1,332 | 235 | $5 | |
84075 |
Phosphatase (enzyme) level, alkaline | 1,332 | 235 | $5 | |
82040 |
Albumin (protein) level | 1,331 | 235 | $5 |
In context: peer comparison
Among 3 peers in Valparaiso Hematology & Oncology Physician, average services per provider: 647. This provider delivers 49× the peer median.Open Payments
Industry payments received
All-time total
$5,812
Transactions
141
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Daiichi Sankyo INC. | 11 | $1,307.02 | |
| Novartis Pharmaceuticals Corporation | 14 | $516.39 | |
| E.R. Squibb & Sons, L.L.C. | 15 | $315.66 | |
| Pfizer INC. | 13 | $282.89 | |
| AstraZeneca Pharmaceuticals Lp | 13 | $271.55 | |
| Merck Sharp & Dohme LLC | 11 | $258.68 | |
| Celgene Corporation | 10 | $217.17 | |
| Gilead Sciences, INC. | 9 | $215.71 | |
| Genentech USA, INC. | 8 | $182.28 | |
| Exelixis INC. | 8 | $176.48 | |
| Eisai INC. | 6 | $143.36 | |
| Genzyme Corporation | 6 | $140.95 | |
| Janssen Biotech, INC. | 7 | $140.16 | |
| Abbvie INC. | 5 | $132.46 | |
| Lilly USA, LLC | 5 | $108.18 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
407
Patients
42
Total drug cost
$3,085,989
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Jakafi (Ruxolitinib Phosphate) | Brand | 97 | 0 | $1,836,545 |
| Anastrozole | Generic | 42 | 17 | $1,739 |
| Imbruvica (Ibrutinib) | Brand | 38 | 0 | $614,311 |
| Prednisone | Generic | 36 | 12 | $307 |
| Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen) | Brand | 27 | 13 | $1,098 |
| Alprazolam | Generic | 22 | 0 | $169 |
| Xarelto (Rivaroxaban) | Brand | 21 | 0 | $21,069 |
| Vonjo (Pacritinib Citrate) | Brand | 19 | 0 | $491,211 |
| Hydroxyurea | Generic | 18 | 0 | $495 |
| Abiraterone Acetate | Generic | 17 | 0 | $103,950 |
Hospital affiliations
Frequently asked questions
What is Dr. Olusola Ogundipe's medical specialty?
Dr. Olusola Ogundipe practices Hematology & Oncology Physician in Valparaiso, IN.
Where does Dr. Olusola Ogundipe practice?
Dr. Olusola Ogundipe practices at 2600 Roosevelt RD, Valparaiso, IN 463830970. Office phone: 2194641620.
What is Dr. Olusola Ogundipe's NPI?
Dr. Olusola Ogundipe's National Provider Identifier (NPI) is 1194849901, issued by NPPES.
Does Dr. Olusola Ogundipe accept Medicare assignment?
Yes. Dr. Olusola Ogundipe accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Olusola Ogundipe commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Injection, ferric derisomaltose, 10 mg (HCPCS J1437); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.